ArticleMedicine2025
Severe pneumomediastinum in an infant with respiratory syncytial virus infection: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleThe respiratory syncytial virus (RSV) is an important cause of bronchiolitis in children, with limited reports of pneumomediastinum as a complication. We report an infant with pneumomediastinum associated with RSV infection requiring intubation. PATIENT CONCERNS: A 4-month-old male infant was diagnosed with RSV infection on the 2nd day of symptom onset (coughing and fever). On the 7th day of symptom onset, chest radiography and computed tomography revealed severe pneumomediastinum, and thus, he was transferred to the intensive care unit. DIAGNOSIS: Severe pneumomediastinum secondary to RSV infection.
interventionsThe patient was intubated, and lung-protective ventilation with muscle relaxants was initiated. After 42 hours of continuous muscle relaxant administration, weaning from mechanical ventilation was started. He was extubated after confirming improved oxygenation and favorable imaging findings. OUTCOMES: The infant recovered completely without further worsening of pneumomediastinum. LESSONS: An infant with severe pneumomediastinum requiring intubation during the course of RSV infection was successfully managed with lung-protective ventilation using muscle relaxants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.